Literature DB >> 1557943

Clinicopathologic correlation and pathogenesis of ocular and central nervous system manifestations in Hallervorden-Spatz syndrome.

R C Tripathi1, B J Tripathi, S C Bauserman, J K Park.   

Abstract

We have correlated the clinical and histopathologic features of the eyes and central nervous system in a patient with Hallervorden-Spatz syndrome who died at age 11 years. The main ocular findings included degeneration of photoreceptors, marked thinning of the outer nuclear and outer plexiform layers, retinal gliosis, narrowing and obliteration of blood vessels with a perivascular cuffing of pigment cells, and degenerative changes in the retinal pigment epithelial cells with accumulation of melanolipofuscin. The positive findings in the brain included a symmetrical, partially destructive lesion of the globus pallidus, especially in its internal fibers and neurons; in addition, we noted gliosis, widely disseminated axonal spheroidal bodies, which were most numerous in the globus pallidus and pars reticulata, as well as deposits of iron. Our histopathologic findings implicate three possible mechanisms, namely, lipid peroxidation, a deficiency of fatty acid membrane components, and increased cGMP which, either singly or in combination, are responsible for a pathogenesis that is common to the eye and brain in Hallervorden-Spatz syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1557943     DOI: 10.1007/bf00308470

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  36 in total

1.  Retinal ultrastructure in advanced retinitis pigmentosa.

Authors:  R B Szamier; E L Berson
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-10       Impact factor: 4.799

2.  Lipid peroxidation in vivo.

Authors:  L A Witting
Journal:  J Am Oil Chem Soc       Date:  1965-11       Impact factor: 1.849

Review 3.  Peroxidation of cell lipids.

Authors:  J M Gutteridge; J Stocks
Journal:  Med Lab Sci       Date:  1976-10

4.  Stimulation of microsomal lipid peroxidation by iron and cysteine. Characterization and the role of free radicals.

Authors:  A J Searle; R L Willson
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

5.  Refsum's syndrome with corneal involvement.

Authors:  J L Baum; M Tannenbaum; E H Kolodny
Journal:  Am J Ophthalmol       Date:  1965-10       Impact factor: 5.258

Review 6.  Phospholipid transfer proteins: mechanism of action.

Authors:  G M Helmkamp
Journal:  J Bioenerg Biomembr       Date:  1986-04       Impact factor: 2.945

7.  Isolation and characterization of human plasma lipid transfer proteins.

Authors:  J J Albers; J H Tollefson; C H Chen; A Steinmetz
Journal:  Arteriosclerosis       Date:  1984 Jan-Feb

8.  In vivo lipid peroxidation in rat brain following intracortical Fe2+ injection.

Authors:  W J Triggs; L J Willmore
Journal:  J Neurochem       Date:  1984-04       Impact factor: 5.372

9.  Vitamin E and neurological function.

Authors:  D P Muller; J K Lloyd; O H Wolff
Journal:  Lancet       Date:  1983-01-29       Impact factor: 79.321

10.  Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus.

Authors:  T L Perry; M G Norman; V W Yong; S Whiting; J U Crichton; S Hansen; S J Kish
Journal:  Ann Neurol       Date:  1985-10       Impact factor: 10.422

View more
  3 in total

1.  Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology.

Authors:  J E Galvin; B Giasson; H I Hurtig; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  Neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Folia Neuropathol       Date:  2005       Impact factor: 2.038

3.  Neuro-ophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome).

Authors:  Robert A Egan; Richard G Weleber; Penelope Hogarth; Allison Gregory; Jason Coryell; Shawn K Westaway; Jane Gitschier; Soma Das; Susan J Hayflick
Journal:  Am J Ophthalmol       Date:  2005-08       Impact factor: 5.258

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.